Skip to content
Screener

Atossa Therapeutics, Inc. ATOS Q4 2025 Annual earnings

Reported March 25, 2026

EPS-$1.19Miss by $0.05
EPS estimate-$1.14

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.92

FAQ

When did Atossa Therapeutics, Inc. report Q4 2025 earnings?
Atossa Therapeutics, Inc. (ATOS) reported Q4 2025 earnings on March 25, 2026.
What were Atossa Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Atossa Therapeutics, Inc. reported eps of $-1.19 for Q4 2025.
Did Atossa Therapeutics, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-1.14 by $0.05.
How did Atossa Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 2280.0% from $-0.05.
Where can I find Atossa Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-124393) and the 10-K periodic report (0001193125-26-124396) directly on SEC EDGAR. The filing index links above go to sec.gov.